BackgroundCheck.run
Search For

Jun Zhao, 581141 Mount Vernon Ave, Lake Forest, IL 60045

Jun Zhao Phones & Addresses

1141 Mount Vernon Ave APT 119, Lake Forest, IL 60045   

Lake Bluff, IL   

Livingston, NJ   

8 Mountainview Rd, Millburn, NJ 07041    973-3795109   

291 Millburn Ave, Millburn, NJ 07041    973-3795109   

Springfield, NJ   

Pine Brook, NJ   

Clifton, NJ   

Edison, NJ   

Piscataway, NJ   

Work

Company: Jun zhao Address: 490 Union Ave Apt B3, Roseland, NJ 07068 Phones: 212-6813117 Position: Executive officer Industries: Legal Services

Mentions for Jun Zhao

Career records & work history

Lawyers & Attorneys

Jun Zhao Photo 1

Jun Zhao - Lawyer

ISLN:
923711244
Admitted:
2006

Medicine Doctors

Jun Zhao

Specialties:
Neurology
Work:
Riverside Medical GroupRiverside Neurology Specialists
12200 Warwick Blvd STE 110, Newport News, VA 23601
757-5345100 (phone) 757-5345395 (fax)
Site
Riverside Medical GroupRiverside Hampton Roads Neurology
850 Enterprise Pkwy STE 1400, Hampton, VA 23666
757-6377500 (phone) 757-6377541 (fax)
Site
Procedures:
Neurological Testing, Sleep and EEG Testing, Lumbar Puncture
Conditions:
Alzheimer's Disease, Carpel Tunnel Syndrome, Dementia, Epilepsy, Hemorrhagic stroke, Ischemic Stroke, Migraine Headache, Multiple Sclerosis (MS), Myasthenia Gravis (MG), Parkinson's Disease, Peripheral Nerve Disorders, Tension Headache
Languages:
English
Description:
Dr. Zhao works in Hampton, VA and 1 other location and specializes in Neurology. Dr. Zhao is affiliated with Riverside Regional Medical Center.

Publications & IP owners

Us Patents

Methods

US Patent:
8183266, May 22, 2012
Filed:
Jun 4, 2008
Appl. No.:
12/663114
Inventors:
Lawrence P. Wennogle - New York NY, US
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Assignee:
Intra-Cellular Therapies, Inc. - New York NY
International Classification:
A61K 31/44
A61K 31/4406
C07D 213/69
C07D 213/68
C07D 213/61
A61P 25/22
US Classification:
514348, 514349, 514351, 546296, 546297, 546300
Abstract:
The invention relates to the novel chemical compounds of the formula (I): (I) in free or salt form, its use in the treatment of NET and/or SERT mediated conditions, e. g. , depression, vasomotor symptoms, e. g. , hot flashes and other diseases or conditions mediated by NET and/or SERT.

Organic Compounds

US Patent:
8536159, Sep 17, 2013
Filed:
Dec 7, 2009
Appl. No.:
13/133033
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zeng - New York NY, US
Lawrence Wennogle - New York NY, US
Assignee:
Intra-Cellular Therapies, Inc. - New York NY
International Classification:
A61K 31/565
A61K 31/519
A61K 31/57
C07D 487/14
US Classification:
514171, 514257, 544247
Abstract:
Optionally substituted 3-(thio, sulfonyl or sulfonyl)-7,8-dihydro-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one or a substituted 3-(thio, sulfinyl or sulfonyl)-7,8,9-trihydro-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidin-4(5H)-one compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Organic Compounds

US Patent:
8633180, Jan 21, 2014
Filed:
Dec 7, 2009
Appl. No.:
13/133082
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zeng - New York NY, US
Lawrence Wennogle - New York NY, US
Assignee:
Intra-Cellular Therapies, Inc. - New York NY
International Classification:
A61K 31/565
A61K 31/57
A61K 31/519
C07D 487/14
US Classification:
514171, 514257, 544247
Abstract:
Optionally substituted 4,5,7,8-tetrahydro-(optionally 4-thioxo or 4-imino)-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidine or 4,5,7,8,9-pentahydro-(optionally 4-thioxo or 4-imino)-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidine compounds or Compounds of Formula (I), processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Organic Compounds

US Patent:
2011028, Nov 17, 2011
Filed:
Dec 7, 2009
Appl. No.:
13/133096
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
Lawrence P. Wennogle - New York NY, US
International Classification:
A61K 31/565
A61K 31/519
A61K 31/57
A61P 25/16
A61P 25/14
A61P 25/28
A61P 25/24
A61P 25/00
A61P 25/22
A61P 25/20
A61P 25/30
A61P 9/00
A61P 9/12
A61P 15/00
A61P 11/06
A61P 11/00
A61P 11/02
A61P 29/00
A61P 37/06
A61P 43/00
A61P 5/14
A61P 15/06
A61P 15/08
A61P 19/10
A61P 35/00
A61P 27/06
A61P 25/18
C07D 487/04
US Classification:
514171, 544262, 5142621
Abstract:
Optionally substituted (5- or 7-amino)-3,4-dihydro-(optionally 4-oxo, 4-thioxo or 4-imino)-1H-pyrrolo[3,4-d]pyrimidin-2(6H)-ones, Compounds of Formula I, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Organic Compounds

US Patent:
2012009, Apr 19, 2012
Filed:
Dec 7, 2009
Appl. No.:
13/132955
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
Lawrence Wennogle - New York NY, US
International Classification:
A61K 31/519
A61K 31/565
A61K 31/57
A61P 25/16
A61P 25/14
A61P 25/28
A61P 25/24
A61P 25/00
A61P 25/22
A61P 25/18
A61P 25/20
A61P 25/30
A61P 9/00
A61P 9/12
A61P 15/00
A61P 11/06
A61P 11/00
A61P 11/02
A61P 37/06
A61P 29/00
A61P 15/12
A61P 5/14
A61P 15/08
A61P 19/10
A61P 13/08
A61P 35/00
A61P 43/00
A61P 27/06
A61P 27/02
C07D 487/04
US Classification:
514171, 544262, 5142621
Abstract:
The present invention relates to optionally substituted 3-amino-4,5-dihydro-(1H or 2H)-pyrazolo[3,4-d]pyrimidin-6(7H)-ones and their 4-imino or 4-thioxo derivatives, e.g., 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo[3,4-d]pyrimidin-6(7H)-ones, 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo[3,4-d]pyrimidin-6(7H)-ones, 3-amino-4-(thioxo or imino)-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6(7H)-ones, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Organic Compounds

US Patent:
2012013, May 31, 2012
Filed:
Dec 7, 2009
Appl. No.:
13/133147
Inventors:
Peng Li - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
Lawrence P. Wennogle - New York NY, US
International Classification:
A61K 31/519
A61P 25/16
A61P 25/00
A61P 25/24
A61P 25/28
A61P 25/22
A61P 25/20
A61P 25/30
A61P 9/00
A61P 9/12
A61P 15/00
A61P 11/06
A61P 29/00
A61P 37/08
A61P 19/10
A61P 15/06
A61P 27/06
A61P 25/18
C07D 487/04
US Classification:
5142651, 544280
Abstract:
Optionally substituted (5- or 7-amino)-3,4-dihydro-(optionally 4-oxo, 4-thioxo or 4-imino)-1H-pyrrolo[3,4-d]pyrimidin-2(6H)-ones, Compounds of Formula I, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

Phosphodiesterase 1-Targeting Tracers And Methods

US Patent:
2012020, Aug 9, 2012
Filed:
Oct 7, 2010
Appl. No.:
13/500941
Inventors:
Peng Li - New York NY, US
Lawrence P. Wennogle - New York NY, US
Jun Zhao - New York NY, US
Hailin Zheng - New York NY, US
International Classification:
A61K 51/04
A61P 25/00
A61P 9/00
C07D 473/06
A61P 9/12
US Classification:
424 189, 544266, 424 165, 424 185, 424 181
Abstract:
Tracers targeting phosphodiesterase 1 for use in gamma radiation detection-based diagnostic techniques, particulaly gamma-emitter labeled tracers for SPECT and positron emitter-labeled compositions for PET are disclosed. Radio-labeled multiple novel scaffolds as PDE1 inhibitors such as substituted pyrazolo-pyrimidin-4-one derivatives, biomarkers for phosphodiesterase 1 [PDE1) in vivo, methods for developing novel therapies for PDE1-implicated conditions such as pulmonary arterial hypertension (PAH), Central Nervous System (CNS) and Cardiovascular (CV) disorders, and methods of detection and treatment are also disclosed.

Organic Compounds

US Patent:
2013008, Apr 4, 2013
Filed:
May 31, 2011
Appl. No.:
13/701235
Inventors:
Peng Li - New York NY, US
Hailin Zheng - New York NY, US
Jun Zhao - New York NY, US
Lawrence P. Wennogle - New York NY, US
Assignee:
INTRA-CELLULAR THERAPIES, INC. - New York NY
International Classification:
C07D 487/14
A61K 45/06
A61K 31/557
A61K 31/19
A61K 31/565
A61K 31/573
A61K 31/519
A61K 31/165
US Classification:
514171, 544247, 514257, 544251, 514267
Abstract:
Optionally substituted 4,5,7,8-tetrahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-(1H or 2H)-imidazo[1,2-a]pyrazolo[4,3-e]pyrimidine or 4,5,7,8,9-pentahydro-(optionally 4-oxo, 4-thioxo or 4-imino)-(1H or 2H)-pyrimido[1,2-a]pyrazolo[4,3-e]pyrimidine compounds, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.